Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	53.84	46.77	30.40
Graham Fair Price	1.38	11.95	11.79
PEG	-692.68	-7.21	-0.91
Price/Book	2.53	1.69	1.65
Price/Cash Flow	249.32	431.59	123.55
Prices/Earnings	8.40	18.49	17.06
Price/Sales	2.04	5.80	5.68
Price/FCF	249.32	431.59	123.55
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-2.78	0.37	0.38
Operating Margin	-5.35	0.12	0.13
ROA	-2.89	< 0.005	< 0.005
ROE	0.02	0.02	-5.41
ROIC	0.03	0.01	-46.80
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	23.41	0.06	39950.85
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.26	< 0.005	97.62
EPS QOQ	-0.19	-0.03	86.32
FCF QOQ	-0.57	-0.69	-21.05
Revenue QOQ	-0.15	0.05	-65.56
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	127.14	121.68	-4.29
Days Sales Outstanding (DSO)	115.89	103.60	-10.61
Inventory Turnover	0.71	0.74	4.49
Debt/Capitalization	0.04	0.46	1171.91
Quick Ratio	0.70	0.82	17.84
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	15.98	16.66	4.24
Cash	1.77	2.36	33.20
Capex	-0.12	-0.15	-25.44
Free Cash Flow	0.21	0.07	-69.40
Revenue	4.64	4.86	4.74
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.12	1.31	17.84
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.85	14.43	1605.27
Naive Interpretation	Member

06 - Financial Health · Weak

Rating